This does not have an impact on TP53 or TERT_prom alterations frequencies, but those of CDKN2A, BAP1, and NF2 are most likely underevaluated as it is the case in most NGS studies due to the contamination of tumor samples by normal cells. The gene discussed is TP53; the disease is neoplasm.